#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Matthew Ekblom Email
QC Analyst . ADC Biotechnology
Deeside,
LocationPrimary Email
How to contact Matthew Ekblom
Join and see Matthew's contact info for free!Current Roles
Employees:
12Revenue:
$1.9MAbout
ADC Biotechnology Ltd was founded in 2010 to develop and commercialise next generation conjugation technologies to the Antibody Drug Conjugate market. Bioconjugation using our proprietary 'Lock-Release' technology involves conjugation of proteins that are immobilised on solid supports, which delivers a number of key product advantages from minimal aggregate formation to minimal residual free drug and enhanced yields. From basic R&D applications through to improved supply economics and product risk management application of our 'Lock-Release' platform drives value through better products delivered with greater efficiency. In addition to technology development, ADC Biotechnology offers a range of technical services, including conjugation (conventional and Lock-Release) to a variety of toxin payloads, toxin-linker design and synthesis and supply of ADCs for proof of concept and toxicology testing. For more information on our services and Lock Release please visit www.adcbio.comADC Biotechnology Address
St Asaph Business ParkDeeside, null